All filters
Slidesets
Opass Putcharoen | HIV Subtypes - Virologic and Resistance Implications
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Slidesets
Mark Nelson | Clinical Case Presentation
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Slidesets
Kiat Ruxrungtham | Two Versus Three Drugs - Relevance for the Asian Settings
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Slidesets
David Back | HIV Gender & Ethnicity - Implications for Toxicity and Altered Pharmacology
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Slidesets
Intestinal Cytotoxic CD4+ T Cells are linked to Immune Activation and Dysbiosis in Untreated HIV Infection - Cara Wilson, MD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Microbiome and Cardiometabolic Risk in HIV and Non-HIV Populations - Marius Troseid, MD, MPH
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Connecting the Dots: Translating the Vaginal Microbiome into a Drug - Laurel Lagenaur, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Impact of Penile Microbiome on Local Immunology and HIV Susceptibility - Rupert Kaul, PhD, MD, FRCPC
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
The Microbiome and SIV Acquisition - Jason Brenchley, MA, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Understanding of the Rectal Mucosal Immune Environment and Potential Impacts on HIV Transmission - Colleen Kelley, MD, MPH
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Probing the Microbiome in Disease: From CRC to HIV - Cynthia Sears, MD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Clinical Update: Highly Treatment- Experienced Patients - Michael Kozal, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents - Catia Marzolini, PharmD, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
HIV Prevention: The Second Wave of Choices - Richard Elion, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
How and When to Monitor Patients On Long-Acting Antivirals? - Monica Gandhi, MD, MPH
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Clinical Case: Reduced Drug Therapy - Mary Montgomery, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CM
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Implications for Sanctuary Sites and Drug Interactions - Marta Boffito, MD, PhD
Presented at:
Global HIV Clinical Forum 2020